Bill could cripple FDA and harm patients; PhRMA
The backlash against the re-importation bill has begun, with PhRMA warning that the legislation could cripple the FDA’s ability to protect patients and open the door to counterfeits.
Archives for March 12, 2009
Driam launches cycled continuous tablet coating system
German coating technology specialist Driam hopes its new Driaconti-T continuous tablet coating platform will win over manufacturers wishing to improve process efficiency in times of economic gloom.
JLL starts Patheon acquisition bid
Private equity firm JLL Patheon Holdings went ahead yesterday with its unsolicited $2-per-share bid for Patheon that would take the company into private ownership.
Pfizer and GSK may feel impact of Wyeth vs. Levine ruling
Drug giants Pfizer and GSK may be among the first affected by last week’s US Supreme Court ruling upholding a product liability lawsuit against Wyeth despite FDA approved labelling.
ACM binds Pivotal into the central laboratory fold
US contract research organisation ACM Global Central Laboratory has bought its longstanding business partner Pivotal Laboratories of the UK in a bid to boost its international reach.
PDII losses mount in “very disappointing” ‘08
The slashing of pharma’s in-house teams did not help contract sales provider PDII in 2008, with the company recording an operating loss of $36.4m (€28.5m), compared with a $14.3m deficit the previous year.